IL115103A0 - Oxa - or thia-aliphatically bridged quinoxaline - 2,3-diones - Google Patents

Oxa - or thia-aliphatically bridged quinoxaline - 2,3-diones

Info

Publication number: IL115103A0
Authority: IL; Israel
Prior art keywords: diones; thia; oxa; bridged quinoxaline; aliphatically
Prior art date: 1994-09-01

Application number

IL11510395A

Other languages

English (en)

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-01

Filing date

1995-08-30

Publication date

1995-12-08

1995-08-30 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1995-12-08 Publication of IL115103A0 publication Critical patent/IL115103A0/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

IL11510395A 1994-09-01 1995-08-30 Oxa - or thia-aliphatically bridged quinoxaline - 2,3-diones IL115103A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH268094		1994-09-01
CH40295		1995-02-09

Publications (1)

Publication Number	Publication Date
IL115103A0 true IL115103A0 (en)	1995-12-08

Family

ID=25684470

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL11510395A IL115103A0 (en)	1994-09-01	1995-08-30	Oxa - or thia-aliphatically bridged quinoxaline - 2,3-diones

Country Status (12)

Country	Link
EP (1)	EP0705835A1 (fr)
JP (1)	JPH08109185A (fr)
KR (1)	KR960010651A (fr)
CN (1)	CN1133844A (fr)
AU (1)	AU3028795A (fr)
BR (1)	BR9503876A (fr)
CA (1)	CA2157231A1 (fr)
FI (1)	FI954072A7 (fr)
HU (1)	HUT73436A (fr)
IL (1)	IL115103A0 (fr)
NO (1)	NO953420L (fr)
NZ (1)	NZ272888A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA9711274B (en) *	1996-12-16	1998-06-23	Warner Lambert Co	Tricyclic quinoxaline derivatives as neuroprotective agents.
US6288075B1 (en)	1998-02-26	2001-09-11	Rhone-Poulenc Rorer S.A.	Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same
FR2760237B1 (fr) *	1997-02-28	1999-04-16	Rhone Poulenc Rorer Sa	Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
FR2766487B1 (fr) *	1997-07-28	1999-08-27	Rhone Poulenc Rorer Sa	Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
LT2502911T (lt)	2004-06-24	2017-09-11	Vertex Pharmaceuticals Incorporated	Atp surišančios kasetės transporterių moduliatoriai
US8354427B2 (en)	2004-06-24	2013-01-15	Vertex Pharmaceutical Incorporated	Modulators of ATP-binding cassette transporters
WO2007079139A2 (fr)	2005-12-28	2007-07-12	Vertex Pharmaceuticals, Inc.	Formes solides de n-[2,4-bis(1,1-diméthyléthyl)-5-hydroxyphényl]-1,4-dihydro-4-oxoquinoléine-3-carboxamide
US12458635B2 (en)	2008-08-13	2025-11-04	Vertex Pharmaceuticals Incorporated	Pharmaceutical composition and administrations thereof
US20100074949A1 (en)	2008-08-13	2010-03-25	William Rowe	Pharmaceutical composition and administration thereof
SI2408750T1 (sl)	2009-03-20	2015-11-30	Vertex Pharmaceuticals Incorporated	Postopek za izdelavo modulatorjev cistično-fibroznega transmembranskega regulatorja prevodnosti
US8802700B2 (en)	2010-12-10	2014-08-12	Vertex Pharmaceuticals Incorporated	Modulators of ATP-Binding Cassette transporters
EP2819670A1 (fr)	2012-02-27	2015-01-07	Vertex Pharmaceuticals Incorporated	Composition pharmaceutique et son administration
KR20170063954A (ko)	2014-10-07	2017-06-08	버텍스 파마슈티칼스 인코포레이티드	낭성 섬유증 막횡단 전도도 조절자의 조정제의 공-결정

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK716188D0 (da) *	1988-12-22	1988-12-22	Ferrosan As	Quinoxalinforbindelser, deres fremstilling og anvendelse
DK715888D0 (da) *	1988-12-22	1988-12-22	Ferrosan As	Quinoxalinforbindelser, deres fremstilling og anvendelse
KR0167346B1 (ko) *	1989-06-09	1999-01-15	로버트 에이. 아미테이지	중추신경계 활성을 갖는 헤테로사이클릭 아민
JPH05117276A (ja) *	1991-10-23	1993-05-14	Sumitomo Pharmaceut Co Ltd	新規な３環性キノキサリンジオン誘導体
EP0647137B1 (fr) *	1992-06-22	2008-08-13	The Regents Of The University Of California	Antagonistes des recepteurs de glycine et leur utilisation
ATE157977T1 (de) *	1992-10-13	1997-09-15	Warner Lambert Co	Chinoxalinderivate als eaa antagonisten
US5631373A (en) *	1993-11-05	1997-05-20	State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon	Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones

1995
- 1995-08-24 EP EP95810529A patent/EP0705835A1/fr not_active Withdrawn
- 1995-08-25 AU AU30287/95A patent/AU3028795A/en not_active Abandoned
- 1995-08-30 JP JP7221931A patent/JPH08109185A/ja active Pending
- 1995-08-30 CA CA002157231A patent/CA2157231A1/fr not_active Abandoned
- 1995-08-30 NZ NZ272888A patent/NZ272888A/en unknown
- 1995-08-30 IL IL11510395A patent/IL115103A0/xx unknown
- 1995-08-30 FI FI954072A patent/FI954072A7/fi not_active Application Discontinuation
- 1995-08-31 KR KR1019950028060A patent/KR960010651A/ko not_active Withdrawn
- 1995-08-31 NO NO953420A patent/NO953420L/no unknown
- 1995-08-31 HU HU9502562A patent/HUT73436A/hu unknown
- 1995-08-31 BR BR9503876A patent/BR9503876A/pt not_active Application Discontinuation
- 1995-08-31 CN CN95117128A patent/CN1133844A/zh active Pending

Also Published As

Publication number	Publication date
FI954072A0 (fi)	1995-08-30
BR9503876A (pt)	1996-09-17
NZ272888A (en)	1997-05-26
HUT73436A (en)	1996-07-29
EP0705835A1 (fr)	1996-04-10
CA2157231A1 (fr)	1996-03-02
NO953420L (no)	1996-03-04
NO953420D0 (no)	1995-08-31
CN1133844A (zh)	1996-10-23
HU9502562D0 (en)	1995-10-30
AU3028795A (en)	1996-03-14
FI954072A7 (fi)	1996-03-02
KR960010651A (ko)	1996-04-20
JPH08109185A (ja)	1996-04-30

Publication	Publication Date	Title
ZA9711092B (en)	1999-07-22	Novel compounds.
EP0676786A3 (fr)	1996-04-24	Dispositif de protection compact.
ZA989767B (en)	2000-04-28	Novel compounds.
GR3022021T3 (en)	1997-03-31	Flashlight.
ZA971645B (en)	1997-12-10	Chemical compounds.
ZA9710314B (en)	1998-05-18	Chemical compounds.
ZA975953B (en)	1998-01-06	Chemical compounds.
ZA975436B (en)	1997-12-22	Chemical Compounds.
ZA975951B (en)	1998-01-06	Chemical compounds.
PL328505A1 (en)	1999-02-01	2-heteroaroylcyclohexano-1,3-diones
EP0664969A3 (fr)	1996-06-26	Chaussure de ski.
ZA9711567B (en)	1998-06-24	Compounds.
IL115103A0 (en)	1995-12-08	Oxa - or thia-aliphatically bridged quinoxaline - 2,3-diones
ZA975280B (en)	1998-01-14	Filter.
ZA975861B (en)	1998-01-30	Bromotiacumicin compounds.
ZA9811503B (en)	2000-06-15	Novel compounds.
ZA9811758B (en)	2000-06-22	Novel compounds.
ZA971676B (en)	1997-09-22	Filter.
ZA956209B (en)	1996-01-29	Azaaliphatically bridged quinoxaline-2,3-diones
ZA979404B (en)	1998-06-01	Aspirinate compounds.
ZA98868B (en)	1999-08-03	Novel compounds.
ZA957307B (en)	1996-03-01	Oxa- or thia-aliphatically bridged quinoxaline-2,3-diones
EP0672364A3 (fr)	1996-06-26	Chaussure de ski.
EP0680970A3 (fr)	1997-05-02	Medrogestrone.
ZA977189B (en)	1998-02-13	Supported chemical compound.